The objective of this Shared Instrument Grant proposal is to obtain instrumentation capable of detecting changes in intracellular ion concentrations by detecting fluorescence from excitable cells loaded with appropriate dyes. Several investigators centered in the Department of Pharmacology need to use the instrumentation requested in order to address significant questions that are specific aims of their research. The specific equipment we wish to purchase consists of a Tracor Northern Fluoroplex III dual excitation fluorescence measuring system for biological samples coupled to a Nikon inverted microscope equipped for fluorescence and attached to both Photomultiplier and Video based Detection. Over the past several years there has been a very rapid growth in NIH funded cellular research at the University of Nevada School of Medicine. This growth has brought together a highly focused group of investigators whose interests center on excitable cells. In order to pursue our various studies of the regulation of cellular physiology by intracellular events, we require up-to-date research capabilities that we can not obtain as individuals. The Fluoroplex III System specified here, represents a fundamental capability that will perform multiple types of analyses. The strength of the equipment requested is that it is capable of three modes of use that will be complimentary. These are a macroscopic mode in which cellular fluorescence can be assessed in a cuvette, a microscopic mode in which fluorescence in a desired location in a cell can be measured with single or dual Photomultipliers, and finally, a video mode in which cellular fluorescence can be acquired with good spatial resolution in two dimensions. The major users of the equipment are a highly interactive group of NIH funded investigators that are studying various aspects of the regulation of contraction of smooth, cardiac, and skeletal muscles, targeted at the understanding of diseases such as cardiac failure, hypertension, asthma, bowel disease and muscular dystrophy. The Fluoroplex system will provide investigators at the University of Nevada with an invaluable research tool that will greatly increase our productivity and research competitiveness. The Dean of the University of Nevada School of Medicine is enthusiastic about this grant and has committed his resources to the installation, support and maintenance of the equipment.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biomedical Research Support Grants (S07)
Project #
2S07RR005876-09
Application #
3516950
Study Section
Special Emphasis Panel (NSS)
Project Start
1983-04-01
Project End
1992-09-29
Budget Start
1991-04-01
Budget End
1992-09-29
Support Year
9
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Whittier Institute for Diabetes & Endoc
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Markoff, E; Beattie, G M; Hayek, A et al. (1990) Effects of prolactin and glycosylated prolactin on (pro)insulin synthesis and insulin release from cultured rat pancreatic islets. Pancreas 5:99-103
Salem, M A; Lewis, U J; Haro, L S et al. (1989) Effects of hypophysectomy and the insulin-like and anti-insulin pituitary peptides on carbohydrate metabolism in yellow Avy/A (BALB/c x VY)F1 hybrid mice. Proc Soc Exp Biol Med 191:408-19
Salem, M A; Wolff, G L (1989) Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice. Proc Soc Exp Biol Med 191:113-23
Markoff, E; Sigel, M B; Lacour, N et al. (1988) Glycosylation selectively alters the biological activity of prolactin. Endocrinology 123:1303-6
Hayek, A; Lopez, A D; Beattie, G M (1988) Decrease in the number of neonatal islets required for successful transplantation by strict metabolic control of diabetic rats. Transplantation 45:940-2
Frigeri, L G; Teguh, C; Ling, N et al. (1988) Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow Avy/A obese mice with amino-terminal peptides of human growth hormone. Endocrinology 122:2940-5
Salem, M A (1988) Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats. Endocrinology 123:1565-76
Frigeri, L G; Wolff, G L; Teguh, C (1988) Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) F1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity. Int J Obes 12:305-20
Culler, F L; Kaufmann, S; Frigeri, L G et al. (1988) Comparison of the acute metabolic effects of 22,000-dalton and 20,000-dalton growth hormone in human subjects. Horm Metab Res 20:107-9
Markoff, E; Lee, D W (1987) Glycosylated prolactin is a major circulating variant in human serum. J Clin Endocrinol Metab 65:1102-6

Showing the most recent 10 out of 15 publications